Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Vilella

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Health Science Reports|March 3, 2022
SARS-CoV2 hospital surveillance and control system with contact tracing for patients and health care workers at a large reference hospital in Spain during the first wave: An observational descriptive studyAnna Llupià, Laura de la Torre-Pérez, Laura Granés, et al.
Ebiomedicine|January 15, 2022
Determinants of early antibody responses to COVID-19 mRNA vaccines in a cohort of exposed and naïve healthcare workersGemma Moncunill, Ruth Aguilar, Marta Ribes, et al.
Transplantation Direct|October 17, 2022
Humoral and Cellular Immune Responses After a 3-dose Course of mRNA-1273 COVID-19 Vaccine in Kidney Transplant Recipients: A Prospective Cohort StudyDavid Cucchiari, Natalia Egri, Diana Rodriguez-Espinosa, et al.
Nature Communications|July 10, 2020
Seroprevalence of antibodies against SARS-CoV-2 among health care workers in a large Spanish reference hospitalAlberto L Garcia-Basteiro, Gemma Moncunill, Marta Tortajada, et al.
The Journal of Infectious Diseases|November 11, 2020
SARS-CoV-2 Seroprevalence and Antibody Kinetics Among Health Care Workers in a Spanish Hospital After 3 Months of Follow-upGemma Moncunill, Alfredo Mayor, Rebeca Santano, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|September 7, 2023
mRNA COVID-19 Vaccination Does Not Exacerbate Symptoms or Trigger Neural Antibody Responses in Multiple SclerosisYolanda Blanco, Domingo Escudero, Cinta Lleixà, et al.
Nature Communications|August 7, 2021
Seven-month kinetics of SARS-CoV-2 antibodies and role of pre-existing antibodies to human coronavirusesNatalia Ortega, Marta Ribes, Marta Vidal, et al.
Iscience|September 17, 2024
Immunogenicity of a third dose with mRNA-vaccines in the ChAdOx1-S/BNT162b2 vaccination regimen against SARS-CoV-2 variantsJavier García-Pérez, Alberto M Borobia, Mayte Pérez-Olmeda, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Health Science Reports|March 3, 2022
SARS-CoV2 hospital surveillance and control system with contact tracing for patients and health care workers at a large reference hospital in Spain during the first wave: An observational descriptive studyAnna Llupià, Laura de la Torre-Pérez, Laura Granés, et al.
Ebiomedicine|January 15, 2022
Determinants of early antibody responses to COVID-19 mRNA vaccines in a cohort of exposed and naïve healthcare workersGemma Moncunill, Ruth Aguilar, Marta Ribes, et al.
Transplantation Direct|October 17, 2022
Humoral and Cellular Immune Responses After a 3-dose Course of mRNA-1273 COVID-19 Vaccine in Kidney Transplant Recipients: A Prospective Cohort StudyDavid Cucchiari, Natalia Egri, Diana Rodriguez-Espinosa, et al.
Nature Communications|July 10, 2020
Seroprevalence of antibodies against SARS-CoV-2 among health care workers in a large Spanish reference hospitalAlberto L Garcia-Basteiro, Gemma Moncunill, Marta Tortajada, et al.
The Journal of Infectious Diseases|November 11, 2020
SARS-CoV-2 Seroprevalence and Antibody Kinetics Among Health Care Workers in a Spanish Hospital After 3 Months of Follow-upGemma Moncunill, Alfredo Mayor, Rebeca Santano, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|September 7, 2023
mRNA COVID-19 Vaccination Does Not Exacerbate Symptoms or Trigger Neural Antibody Responses in Multiple SclerosisYolanda Blanco, Domingo Escudero, Cinta Lleixà, et al.
Nature Communications|August 7, 2021
Seven-month kinetics of SARS-CoV-2 antibodies and role of pre-existing antibodies to human coronavirusesNatalia Ortega, Marta Ribes, Marta Vidal, et al.
Iscience|September 17, 2024
Immunogenicity of a third dose with mRNA-vaccines in the ChAdOx1-S/BNT162b2 vaccination regimen against SARS-CoV-2 variantsJavier García-Pérez, Alberto M Borobia, Mayte Pérez-Olmeda, et al.
Pageof 5